SELLAS Life Sciences (SLS) Current Deferred Revenue (2020 - 2021)
SELLAS Life Sciences (SLS) has disclosed Current Deferred Revenue for 3 consecutive years, with $900000.0 as the latest value for Q1 2021.
- Quarterly Current Deferred Revenue changed N/A to $900000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $5.6 million for FY2020, N/A changed from the prior year.
- Current Deferred Revenue for Q1 2021 was $900000.0 at SELLAS Life Sciences, down from $5.6 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $5.6 million in Q4 2020, with the low at $900000.0 in Q1 2021.